Science Explorer Interactive view Map
Company · Paris · France

Hybrigenics (France)

hybrigenics-services.comROR OpenAlex
Research works
92
▼ 59% vs 2013–17
Citations
5.5k
59.7 per fractional work
Top-10% rate
24.4%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Hybrigenics (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 8.35× its world share, 2 worksBiochemistry, Geneti…Neuroscience: 3.52× its world share, 0 worksNeuroscienceEnergy: 2.51× its world share, 0 worksEnergyEngineering: 0.15× its world share, 0 worksEngineeringMaterials Science: 0.66× its world share, 0 worksMaterials ScienceMedicine: 1.87× its world share, 1 worksMedicineSocial Sciences: 0.55× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.3×. Every wedge is a field page.

Which keywords describe research at Hybrigenics (France)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Gene Set Enrichment Analysis, Protein-Protein Interaction Networks, Proteasome Inhibitors, Proteasome, Ubiquitin, Gene Expression and Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy14▲ 23×8 topics
  2. Gene Set Enrichment Analysis8▲ 247×1 topic
  3. Protein-Protein Interaction Networks8▲ 247×1 topic
  4. Proteasome Inhibitors7▲ 112×2 topics
  5. Proteasome6▲ 176×1 topic
  6. Ubiquitin6▲ 176×1 topic
  7. Cancer6▲ 4.8×23 topics
  8. Gene Expression5▲ 9.4×6 topics
  9. Inflammation4▲ 1.85×18 topics
  10. Angiogenesis4▲ 9.7×6 topics
  11. Machine Learning4▲ 1.76×4 topics
  12. Metabolic Engineering3▲ 28×3 topics
  13. Constraint-Based Models3▲ 59×1 topic
  14. Genome-Scale Models3▲ 59×1 topic
  15. Transcriptional Regulation3▲ 13×6 topics
  16. Cancer Progression3▲ 14×6 topics
  17. Epigenetic Regulation3▲ 14×5 topics
  18. Immune Response3▲ 4.8×12 topics
  19. Protein-Protein Interactions2▲ 25×3 topics
  20. Apoptosis2▲ 6.6×8 topics
  21. Bioinformatics2▲ 23×3 topics
  22. Medicinal Chemistry2▲ 6.9×3 topics
  23. Mitochondria2▲ 15×4 topics
  24. Regulation2▲ 4.1×6 topics
  25. Cellular Functions2▲ 31×2 topics
  26. HDAC Inhibitors2▲ 120×1 topic
  27. Histone Deacetylases2▲ 120×1 topic
  28. PET Imaging2▲ 10×2 topics
  29. Prophylaxis2▲ 16×3 topics
  30. Tumor Suppression2▲ 20×3 topics
  31. Biotin2▲ 128×1 topic
  32. Immunosuppression2▲ 19×2 topics
  33. Proximity Labeling2▲ 128×1 topic
  34. Tumor Microenvironment2▲ 6.2×3 topics
  35. Fibroblast Activation Protein2▲ 40×1 topic
  36. N-terminal Acetylation2▲ 40×1 topic
  37. Therapeutic Targets2▲ 9.0×4 topics
  38. Signal Transduction2▲ 8.2×3 topics
  39. Genetic Code2▲ 14×2 topics
  40. Endocytosis2▲ 38×1 topic

Which research topics does Hybrigenics (France) publish most on?

By volume in 2022–2025: Ubiquitin and proteasome pathways, Peptidase Inhibition and Analysis, Genetics and Neurodevelopmental Disorders and Monoclonal and Polyclonal Antibodies Research.

Ubiquitin and proteasome pathways: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksGenetics and Neurodevelo…0Genetics and Neurodevelopmental Disorders: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksSpaceflight effects on biology: 0 fractional worksAlzheimer's disease research and treatments: 0 fractional worksBiochemical and Structural Characterization: 0 fractional worksAmino Acid Enzymes and Metabolism: 0 fractional worksNeuroscience and Neuropharmacology Research: 0 fractional worksReceptor Mechanisms and Signaling: 0 fractional works
Molecular BiologyOncologyGeneticsRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ubiquitin and proteasome pathways Molecular Biology 0 works
  2. 2 Peptidase Inhibition and Analysis Oncology 0 works
  3. 3 Genetics and Neurodevelopmental Disorders Genetics 0 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Spaceflight effects on biology Physiology 0 works
  6. 6 Alzheimer's disease research and treatments Physiology 0 works
  7. 7 Biochemical and Structural Characterization Molecular Biology 0 works
  8. 8 Amino Acid Enzymes and Metabolism Biochemistry 0 works
  9. 9 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 0 works
  10. 10 Receptor Mechanisms and Signaling Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.6%not open65.4%

World: 28% of research is openly available.

with international co-authors36.3%domestic only63.7%

World: 19% is written across borders.

How has Hybrigenics (France)'s research output changed?

Output in 2018–2022 was 59% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.